Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 9Th December, 2023 As Per Regulation 30 Of SEBI (LODR) Regulations, 2015

Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. Saturday, 9th December, 2023 at the Registered Office of the Company, which commenced at 3:00 P. M. and concluded at 4:30 P. M. inter-alia, has consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended on 30th September, 2023 along with Limited Review Report.
09-12-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Reg. 34 (1) Annual Report.

Kindly find the attached Annual Report of the Company.
13-10-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Kindly find attached compliance certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulations, 2018.
10-10-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Closure of Trading Window

Kindly find the attached intimation for closure of trading window.
30-09-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Reg. 34 (1) Annual Report.

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit Revised Annual Report for the Financial Year 2019-20 as few information were inadvertently not mentioned in the earlier submitted Annual Report.
29-09-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Intimation Of Record Date For Sub-Division/Split Of Equity Shares Of The Company

Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Company has fixed Thursday, 5th October, 2023 as the Record date for the purpose of ascertaining the eligibility of shareholders entitled for Sub-division / Split of 1 Equity share having face value of Rs. 2/- each into 2 Equity shares having face value of Re. 1/- each.
23-09-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Scrutinizer Report for Annual General Meeting of 2022-23
18-09-2023
Bigul

Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of the Annual General Meeting held on 16th September, 2023 in term of the Regulation 30 of the SEBI (LODR) Regulations, 2015.
16-09-2023
Next Page
Close

Let's Open Free Demat Account